Need help finding what you are looking for?
Contact Us
PUBLISHER: DelveInsight | PRODUCT CODE: 1049398
PUBLISHER: DelveInsight | PRODUCT CODE: 1049398
Anorexia - Epidemiology Forecast - 2032
PUBLISHED:
PAGES: 53 Pages
DELIVERY TIME: 1-3 business days
SELECT AN OPTION
DelveInsight's 'Anorexia Nervosa (AN)- Epidemiology Forecast-2032' report delivers an in-depth understanding of AN, historical and forecasted epidemiology as well as AN trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
Anorexia Nervosa Disease Understanding
Anorexia nervosa (AN) is an eating disorder characterized by weight loss or lack of appropriate weight gain in growing children; difficulties maintaining an appropriate body weight for height, age, and stature; and, in many individuals, distorted body image. People with anorexia generally restrict the number of calories and the types of food they eat.
This disorder is characterized by deliberate weight loss, induced and sustained by the patient. It occurs most commonly in adolescent girls and young women, but adolescent boys and young men may also be affected, as many children approaching puberty and older women up to the menopause. The disorder is associated with specific psychopathology whereby a dread of fatness and flabbiness of body contour persists as an intrusive, overvalued idea, and the patients impose a low weight threshold on themselves. There is usually under nutrition of varying severity with secondary endocrine and metabolic changes and disturbances of bodily function.
Anorexia Nervosa Diagnosis
No objective test-such as bloodwork or an X-ray-can definitively point to an eating disorder. Instead, a doctor makes the diagnosis based on a person's symptoms. To diagnose anorexia, the doctor will ask about the person's symptoms, and they may also ask family members and other loved ones about their observations. If a doctor believes that a person has anorexia, they will attempt to diagnose the type. One type primarily involves restricting food intake, while another involves episodes of overeating and purging. If the person has experienced at least one of these episodes in the past 3 months, the doctor will likely diagnose binge eating and purging anorexia.
Diagnostic instruments in the form of questionnaires are used. Few of them are as follows:
- Structured Inventory for Anorexic and Bulimic Eating Disorders Self-Report (SIAB-S)
- Munich Eating and Feeding Disorder Questionnaire (Munich ED-Quest):
- Eating Disorder Examination-Questionnaire for children (ChEDE-Q):
- The SCOFF questionnaire
Continued in the report…..
Anorexia Nervosa Epidemiology Perspective by DelveInsight
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent cases of anorexia nervosa, diagnosed prevalent cases of anorexia nervosa and gender-specific diagnosed prevalent cases of anorexia nervosa, scenario of Anorexia Nervosa in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.
Anorexia Nervosa Detailed Epidemiology Segmentation
- Total prevalent cases of anorexia nervosa in the 7MM were found to be approximately 1,692,817 in 2021. These cases are expected to increase by 2032 at a CAGR of 0.3% during the study period (2019-2032).
- Among 7MM, the United States has the highest prevalent cases of anorexia nervosa with 703,497 cases in 2021.
- The total diagnosed prevalent cases of anorexia nervosa in the 7MM were observed to be 812,552 in 2021. These cases are expected to increase during the study period (2019-2032).
- Among the European countries, Germany had the highest diagnosed prevalent population of Anorexia nervosa with 86,928 cases, followed by the UK with 69,732 cases in 2021. On the other hand, Spain had the lowest diagnosed prevalent population.
- In Japan, 128,408 diagnosed prevalent cases of anorexia nervosa were recorded in the year 2021.
- As per DelveInsight's assessment, for anorexia nervosa, the gender-specific distribution of the disease suggests females at a higher count with 763,335 cases in the 7MM, in 2021.
Scope of the Report:
- The report covers the descriptive overview of anorexia nervosa, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
- The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The report assesses the disease risk and burden of anorexia nervosa.
- The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
- The report provides the segmentation of the disease epidemiology for 7MM, a total number of prevalent cases of anorexia nervosa, diagnosed prevalent cases of anorexia nervosa and gender-specific diagnosed prevalent cases of anorexia nervosa.
Report Highlights:
- 11-Year Forecast of Anorexia nervosa
- The 7MM Coverage
- Total prevalent cases of anorexia nervosa
- Diagnosed prevalent cases of anorexia nervosa
- Gender-specific diagnosed prevalent cases of anorexia nervosa
Key Questions Answered
- What are the disease risk and burdens of anorexia nervosa?
- What is the historical anorexia nervosa patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
- What would be the forecasted patient pool of anorexia nervosa at the 7MM level?
- What will be the growth opportunities across the 7MM concerning the patient population about anorexia nervosa?
- Out of the above-mentioned countries, which country would have the highest diagnosed prevalent population of anorexia nervosa during the forecast period (2022-2032)?
- At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?
Reasons to buy:
The anorexia nervosa report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the 7MM anorexia nervosa epidemiology forecast.
- The anorexia nervosa epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
- The anorexia nervosa epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2019-2032.
Product Code: DIEI1168
Table of Contents
1. Key Insights
2. Report Introduction
3. Anorexia Nervosa Patient Overview at a Glance
- 3.1. Patient Share (%) Distribution of Anorexia Nervosa by Therapies in 2019
- 3.2. Patient Share (%) Distribution of Anorexia Nervosa by Therapies in 2032
4. Executive Summary of Anorexia nervosa
5. Disease Background and Overview: Anorexia Nervosa (AN)
- 5.1. Introduction of Anorexia Nervosa
- 5.2. Types of Anorexia Nervosa
- 5.3. Risk factors of Anorexia Nervosa
- 5.4. Symptoms of Anorexia Nervosa
- 5.5. Comorbidities of Anorexia Nervosa
- 5.6. Etiology of Anorexia Nervosa
- 5.7. Pathophysiology of Anorexia Nervosa
- 5.8. Diagnostic Approach of Anorexia Nervosa
- 5.8.1. Diagnostic Guidelines
- 5.8.1.1. DSM-5 Diagnostic Criteria
- 5.8.1.2. ICD-11 diagnostic criteria (6B10)
- 5.8.1.3. ICD-10 diagnostic criteria (FB50.0)
- 5.8.1.4. German Guidelines on Fluency Disorders based on ICF mode
- 5.8.1. Diagnostic Guidelines
6. Epidemiology and Patient Population
- 6.1. Key Findings
- 6.2. Methodology of Epidemiology
- 6.3. Assumptions and Rationale: 7MM
- 6.4. Total Prevalent Cases of Anorexia Nervosa in the 7MM
- 6.5. Total Diagnosed Prevalent Cases of Anorexia Nervosa in the 7MM
- 6.6. The United States
- 6.6.1. Total Prevalent Cases of Anorexia Nervosa in the United States
- 6.6.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in the United States
- 6.6.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in the United States
- 6.7. Major Five European Countries
- 6.7.1. Germany
- 6.7.1.1. Total Prevalent Cases of Anorexia Nervosa in Germany
- 6.7.1.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in Germany
- 6.7.1.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in Germany
- 6.7.2. France
- 6.7.2.1. Total Prevalent Cases of Anorexia Nervosa in France
- 6.7.2.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in France
- 6.7.2.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in France
- 6.7.3. Italy
- 6.7.3.1. Total Prevalent Cases of Anorexia Nervosa in Italy
- 6.7.3.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in Italy
- 6.7.3.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in Italy
- 6.7.4. Spain
- 6.7.4.1. Total Prevalent Cases of Anorexia Nervosa in Spain
- 6.7.4.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in Spain
- 6.7.4.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in Spain
- 6.7.5. UK
- 6.7.5.1. Total Prevalent Cases of Anorexia Nervosa in the UK
- 6.7.5.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in the UK
- 6.7.5.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in the UK
- 6.7.1. Germany
- 6.8. Japan
- 6.8.1. Total Prevalent Cases of Anorexia Nervosa in Japan
- 6.8.2. Total Diagnosed Prevalent Cases of Anorexia Nervosa in Japan
- 6.8.3. Gender-specific Diagnosed Prevalent Cases of Anorexia Nervosa in Japan
7. Patient Journey
8. Key Opinion Leaders' Views
9. Appendix
- 9.1. Bibliography
- 9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Product Code: DIEI1168
List of Tables
- Table 1: Summary of Anorexia nervosa, and Epidemiology (2019-2032)
- Table 2: Risk Factor Chart
- Table 3: Symptoms of Anorexia nervosa
- Table 4: Diagnostic Instruments for anorexia nervosa
- Table 5: Total Prevalent Cases of Anorexia nervosa in the 7MM, in '000' (2019-2032)
- Table 6: Total Diagnosed Prevalent Cases of Anorexia nervosa in the 7MM, in '000' (2019-2032)
- Table 7: Prevalent Cases of Anorexia nervosa in the US, in '000' (2019-2032)
- Table 8: Diagnosed Prevalent Cases of Anorexia nervosa in the US, in '000' (2019-2032)
- Table 9: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in the US, in '000' (2019-2032)
- Table 10: Prevalent Cases of Anorexia nervosa in Germany, in '000' (2019-2032)
- Table 11: Diagnosed Prevalent Cases of Anorexia nervosa in Germany, in '000' (2019-2032)
- Table 12: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Germany, in '000' (2019-2032)
- Table 13: Prevalent Cases of Anorexia nervosa in France, in '000' (2019-2032)
- Table 14: Diagnosed Prevalent Cases of Anorexia nervosa in France, in '000' (2019-2032)
- Table 15: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in France, in '000' (2019-2032)
- Table 16: Prevalent Cases of Anorexia nervosa in Italy, in '000' (2019-2032)
- Table 17: Diagnosed Prevalent Cases of Anorexia nervosa in Italy, in '000' (2019-2032)
- Table 18: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Italy, in '000' (2019-2032)
- Table 19: Prevalent Cases of Anorexia nervosa in Spain, in '000' (2019-2032)
- Table 20: Diagnosed Prevalent Cases of Anorexia nervosa in Spain, in '000' (2019-2032)
- Table 21: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Spain, in '000' (2019-2032)
- Table 22: Prevalent Cases of Anorexia nervosa in the UK, in '000' (2019-2032)
- Table 23: Diagnosed Prevalent Cases of Anorexia nervosa in the UK, in '000' (2019-2032)
- Table 24: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in the UK, in '000' (2019-2032)
- Table 25: Prevalent Cases of Anorexia nervosa in Japan, in '000' (2019-2032)
- Table 26: Diagnosed Prevalent Cases of Anorexia nervosa in Japan, in '000' (2019-2032)
- Table 27: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Japan, in '000' (2019-2032)
List of Figures
- Figure 1: Subtypes of Eating Disorders
- Figure 2: Types of Eating Disorders
- Figure 3: Primary Behaviours of Anorexia nervosa
- Figure 4: Etiology of Anorexia nervosa
- Figure 5: Causes of Anorexia nervosa
- Figure 6: Total Prevalent Cases of Anorexia nervosa in the 7MM, in '000' (2019-2032)
- Figure 7: Total Diagnosed Prevalent Cases of Anorexia nervosa in the 7MM, in '000' (2019-2032)
- Figure 8: Prevalent Cases of Anorexia nervosa in the US, in '000' (2019-2032)
- Figure 9: Diagnosed Prevalent Cases of Anorexia nervosa in the US, in '000' (2019-2032)
- Figure 10: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in the US, in '000' (2019-2032)
- Figure 11: Prevalent Cases of Anorexia nervosa in Germany, in '000' (2019-2032)
- Figure 12: Diagnosed Prevalent Cases of Anorexia nervosa in Germany, in '000' (2019-2032)
- Figure 13: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Germany, in '000' (2019-2032)
- Figure 14: Prevalent Cases of Anorexia nervosa in France, in '000' (2019-2032)
- Figure 15: Diagnosed Prevalent Cases of Anorexia nervosa in France, in '000' (2019-2032)
- Figure 16: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in France, in '000' (2019-2032)
- Figure 17: Prevalent Cases of Anorexia nervosa in Italy, in '000' (2019-2032)
- Figure 18: Diagnosed Prevalent Cases of Anorexia nervosa in Italy, in '000' (2019-2032)
- Figure 19: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Italy, in '000' (2019-2032)
- Figure 20: Prevalent Cases of Anorexia nervosa in Spain, in '000' (2019-2032)
- Figure 21: Diagnosed Prevalent Cases of Anorexia nervosa in Spain, in '000' (2019-2032)
- Figure 22: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Spain, in '000' (2019-2032)
- Figure 23: Prevalent Cases of Anorexia nervosa in the UK, in '000' (2019-2032)
- Figure 24: Diagnosed Prevalent Cases of Anorexia nervosa in the UK, in '000' (2019-2032)
- Figure 25: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in the UK, in '000' (2019-2032)
- Figure 26: Prevalent Cases of Anorexia nervosa in Japan, in '000' (2019-2032)
- Figure 27: Diagnosed Prevalent Cases of Anorexia nervosa in Japan, in '000' (2019-2032)
- Figure 28: Gender-specific Diagnosed Prevalent Cases of Anorexia nervosa in Japan, in '000' (2019-2032)
- Figure 29: Patient Journey
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.